Close

Analyst Ratings for Ultragenyx Pharma (RARE) [Sells]

RARE Rating Summary

RARE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RARE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $94.15 (+101.7%) * Over Last 12-Mos
Rating Score: 7.9 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/19/2021 UBS N/A New Coverage Sell
(N/A)
73.00
(N/A)
81.96
(46.69)
-43.03% Details
Like RARE Ratings? Also take a look at MREO, CADL, RCKT, TSVT

RARE Ratings News